Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA endonuclease activity	ERCC4 ZRANB3 MBD4 RAG1 SETMAR	6.10e-05	44	191	5	GO:0004520
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	PCDHA9 FAT1 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHA7 PCDHGB4 DSG4 CDH9	9.14e-06	187	189	10	GO:0007156
Domain	Cadherin_CS	PCDHA9 FAT1 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHA7 PCDHGB4 DSG4 CDH9	1.51e-07	109	188	10	IPR020894
Domain	CADHERIN_1	PCDHA9 FAT1 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHA7 PCDHGB4 DSG4 CDH9	2.13e-07	113	188	10	PS00232
Domain	Cadherin	PCDHA9 FAT1 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHA7 PCDHGB4 DSG4 CDH9	2.13e-07	113	188	10	PF00028
Domain	CADHERIN_2	PCDHA9 FAT1 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHA7 PCDHGB4 DSG4 CDH9	2.31e-07	114	188	10	PS50268
Domain	-	PCDHA9 FAT1 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHA7 PCDHGB4 DSG4 CDH9	2.31e-07	114	188	10	2.60.40.60
Domain	CA	PCDHA9 FAT1 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHA7 PCDHGB4 DSG4 CDH9	2.51e-07	115	188	10	SM00112
Domain	Cadherin-like	PCDHA9 FAT1 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHA7 PCDHGB4 DSG4 CDH9	2.72e-07	116	188	10	IPR015919
Domain	Cadherin	PCDHA9 FAT1 PCDHGB5 PCDHGB2 FAT3 PCDH11Y PCDHA7 PCDHGB4 DSG4 CDH9	3.20e-07	118	188	10	IPR002126
Domain	Cadherin_tail	PCDHA9 PCDHGB5 PCDHGB2 PCDHA7 PCDHGB4	3.29e-05	37	188	5	PF15974
Domain	Cadherin_CBD	PCDHA9 PCDHGB5 PCDHGB2 PCDHA7 PCDHGB4	3.29e-05	37	188	5	IPR031904
Domain	Cadherin_2	PCDHA9 PCDHGB5 PCDHGB2 PCDH11Y PCDHA7 PCDHGB4	4.84e-05	65	188	6	PF08266
Domain	Cadherin_N	PCDHA9 PCDHGB5 PCDHGB2 PCDH11Y PCDHA7 PCDHGB4	4.84e-05	65	188	6	IPR013164
Domain	Cadherin_C	PCDHA9 PCDHGB5 PCDHGB2 PCDHA7 PCDHGB4	6.16e-05	42	188	5	IPR032455
Domain	Cadherin_C_2	PCDHA9 PCDHGB5 PCDHGB2 PCDHA7 PCDHGB4	6.16e-05	42	188	5	PF16492
Domain	Factor_5/8	F5 F8	1.01e-04	2	188	2	IPR024715
Domain	Dystrophin	DMD UTRN	1.01e-04	2	188	2	IPR016344
Domain	Amyloid_glyco_E2_domain	APLP2 APP	3.00e-04	3	188	2	IPR024329
Domain	A4_EXTRA	APLP2 APP	3.00e-04	3	188	2	PS00319
Domain	Amyloid_glyco_heparin-bd	APLP2 APP	3.00e-04	3	188	2	IPR015849
Domain	A4_INTRA	APLP2 APP	3.00e-04	3	188	2	PS00320
Domain	-	APLP2 APP	3.00e-04	3	188	2	3.90.570.10
Domain	APP_N	APLP2 APP	3.00e-04	3	188	2	PF02177
Domain	APP_Cu_bd	APLP2 APP	3.00e-04	3	188	2	PF12924
Domain	APP_E2	APLP2 APP	3.00e-04	3	188	2	PF12925
Domain	APP_amyloid	APLP2 APP	3.00e-04	3	188	2	PF10515
Domain	Amyloid_glyco	APLP2 APP	3.00e-04	3	188	2	IPR008155
Domain	Amyloid_glyco_extra	APLP2 APP	3.00e-04	3	188	2	IPR008154
Domain	-	APLP2 APP	3.00e-04	3	188	2	3.30.1490.140
Domain	APP_amyloid_C	APLP2 APP	3.00e-04	3	188	2	IPR019543
Domain	Amyloid_glyco_extracell_CS	APLP2 APP	3.00e-04	3	188	2	IPR019744
Domain	Amyloid_glyco_intracell_CS	APLP2 APP	3.00e-04	3	188	2	IPR019745
Domain	Amyloid_glyco_Cu-bd	APLP2 APP	3.00e-04	3	188	2	IPR011178
Domain	A4_EXTRA	APLP2 APP	3.00e-04	3	188	2	SM00006
Domain	USP_CS	CYLD USP34 USP31 USP42 USP28	5.33e-04	66	188	5	IPR018200
Domain	USP_1	CYLD USP34 USP31 USP42 USP28	6.98e-04	70	188	5	PS00972
Domain	ZF_ZZ_2	DMD UTRN CREBBP	7.33e-04	18	188	3	PS50135
Domain	ZF_ZZ_1	DMD UTRN CREBBP	7.33e-04	18	188	3	PS01357
Domain	ZZ	DMD UTRN CREBBP	7.33e-04	18	188	3	PF00569
Domain	UCH	CYLD USP34 USP31 USP42 USP28	7.45e-04	71	188	5	PF00443
Domain	USP_2	CYLD USP34 USP31 USP42 USP28	7.45e-04	71	188	5	PS00973
Domain	USP_3	CYLD USP34 USP31 USP42 USP28	7.94e-04	72	188	5	PS50235
Domain	USP_dom	CYLD USP34 USP31 USP42 USP28	7.94e-04	72	188	5	IPR028889
Domain	Peptidase_C19_UCH	CYLD USP34 USP31 USP42 USP28	7.94e-04	72	188	5	IPR001394
Domain	Znf_ZZ	DMD UTRN CREBBP	8.64e-04	19	188	3	IPR000433
Domain	ZnF_ZZ	DMD UTRN CREBBP	8.64e-04	19	188	3	SM00291
Domain	Cu-oxidase_3	F5 F8	9.88e-04	5	188	2	IPR011707
Domain	MULTICOPPER_OXIDASE1	F5 F8	9.88e-04	5	188	2	PS00079
Domain	Cu_oxidase_CS	F5 F8	9.88e-04	5	188	2	IPR033138
Domain	Cu-oxidase_3	F5 F8	9.88e-04	5	188	2	PF07732
Domain	Cu_oxidase_Cu_BS	F5 F8	1.47e-03	6	188	2	IPR002355
Domain	EF-hand_dom_typ1	DMD UTRN	1.47e-03	6	188	2	IPR015153
Domain	EF-hand_dom_typ2	DMD UTRN	1.47e-03	6	188	2	IPR015154
Domain	EF-hand_2	DMD UTRN	1.47e-03	6	188	2	PF09068
Domain	EF-hand_3	DMD UTRN	1.47e-03	6	188	2	PF09069
Domain	Spectrin	DMD UTRN SPTBN4	1.53e-03	23	188	3	PF00435
Domain	ACTININ_2	DMD UTRN SPTBN4	1.53e-03	23	188	3	PS00020
Domain	ACTININ_1	DMD UTRN SPTBN4	1.53e-03	23	188	3	PS00019
Domain	Actinin_actin-bd_CS	DMD UTRN SPTBN4	1.53e-03	23	188	3	IPR001589
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	EMC1 RPLP0 RPN1 DHX38 RTN3 MCM3 NEK9 GFPT1 CLTC CPSF1 DLAT PRMT1 AFDN KIF5B HSPA4 IQGAP3 IPO5 NPEPPS NOC3L NDFIP2 DUOX2 APLP2 LRRC40 SEC31A PRDX2 LAP3 MTHFD1 SEC23IP GIGYF2 SPEN	4.10e-10	1425	194	30	30948266
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RPLP0 RPN1 CFL2 RSF1 ZBTB41 CREBRF MFAP1 RINT1 SACS FAM161A CLTC VPS13A DLAT KIF5B DMD PCDHGB5 PCDHGB2 NOC3L SLC44A2 DUOX2 DHX57 TEX14 TRIM16 SPTBN4 SEC23IP MARF1 PCDHGB4 CEP295 SPEN DNAJC5B	5.42e-10	1442	194	30	35575683
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 ATXN2L RPLP0 DHX38 RSF1 GFPT1 ATAD2B CLTC CPSF1 DLAT AFDN KIF5B UTRN HSPA4 IPO5 NPEPPS NOC3L DHX57 GIGYF2 SPEN	9.04e-10	653	194	20	22586326
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ATXN2L RPLP0 RPN1 MCM3 GFPT1 ADCY9 PRUNE1 PRMT1 AFDN KIF5B HSPA4 IPO5 ANK3 LRRC40 XPNPEP1 SEC31A MTHFD1 SEC23IP GIGYF2 CRYBG3	3.57e-09	708	194	20	39231216
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CYLD MCM3 ARMCX4 NEK9 CLTC PRMT1 AFDN KIF5B MGA SGIP1 ANK3 NACC1 USP28 NPEPPS SEC31A PRDX2 SPTBN4 GDA FRY SEC23IP NT5C2 GIGYF2 WDFY3	5.40e-09	963	194	23	28671696
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RPN1 DHX38 RSF1 MCM3 NEK9 GFPT1 MFAP1 CLTC CPSF1 DLAT PRMT1 AFDN KIF5B MGA UTRN HSPA4 RASA3 NPEPPS NOC3L DHX57 LRRC40 SEC31A PRDX2 ERI1 CREBBP MTHFD1 WDFY3	1.04e-08	1353	194	27	29467282
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CYLD USP34 RELN ARMCX4 GFPT1 NAA25 SACS SERGEF CLTC DLAT AFDN MBD4 UTRN IPO5 SETMAR ANK3 USP28 SEC31A APP CREBBP SPTBN4 FRY NAPB SEC23IP KDM4A WDFY3	1.52e-08	1285	194	26	35914814
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	CYLD USP34 MCM3 ADCY9 DMXL1 FAT1 CLTC VPS13A AFDN MGA ANK3 NOC3L SEC31A TEX9 DNAH7 CNNM3 MTHFD1 SEC23IP SPEN XPR1	1.69e-08	777	194	20	35844135
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	RELN PCDHA9 PCDHGB5 PCDHGB2 PCDHA7 NKX2-1 PCDHGB4	3.15e-08	57	194	7	32633719
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATXN2L DDAH1 RPLP0 RPN1 CFL2 RTN3 HDHD2 USP31 SACS CLTC DLAT AFDN KIF5B DMD UTRN HSPA4 IPO5 SGIP1 ANK3 MTERF1 NPEPPS DHX57 PRDX2 SPTBN4 GDA NAPB MTHFD1	3.31e-08	1431	194	27	37142655
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	EMC1 RPLP0 MCM3 F5 MFAP1 SACS CLTC CPSF1 PRMT1 AFDN KIF5B MGA UTRN HSPA4 IPO5 NPEPPS LRRC40 APP CNNM3 MTHFD1 GIGYF2 SPEN	7.63e-08	1024	194	22	24711643
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ATXN2L RPN1 CDK12 MCM3 NEK9 PRUNE1 CLTC AFDN KIF5B MGA ANK3 CREBBP MTMR6 SEC23IP GIGYF2 SPEN	9.23e-08	549	194	16	38280479
Pubmed	14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.	MCM3 CLTC KIF5B HSPA4 IPO5 APP GDA MTHFD1 FLAD1 NT5C2	1.06e-07	186	194	10	14744259
Pubmed	New insights on the functional role of URG7 in the cellular response to ER stress.	RPLP0 GFPT1 CLTC IPO5 SEC31A PRDX2	2.47e-07	47	194	6	29704455
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHA9 PCDHGB5 PCDHGB2 PCDH11Y PCDHA7 PCDHGB4 CDH9	2.61e-07	77	194	7	10835267
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CYLD EMC1 RPLP0 RPN1 RTN3 ADCY9 DMXL1 USP31 MFAP1 RINT1 SACS CLTC VPS13A DLAT TMX3 HSPA4 CASP8AP2 ANK3 POLE2 NOC3L LRRC40 APP CNNM3 CRYBG3 DNAJC5B XPR1	2.66e-07	1487	194	26	33957083
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ATXN2L RPLP0 CDK12 DHX38 RSF1 NEK9 GFPT1 PRUNE1 PRMT1 KIF5B UTRN HSPA4 NACC1 USP28 NOC3L TACC2 PRDX2 MTHFD1 SEC23IP GIGYF2	3.26e-07	934	194	20	33916271
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA9 PCDHGB5 PCDHGB2 PCDHA7 PCDHGB4	4.54e-07	28	194	5	15347688
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CYLD ATXN2L EMC1 RPLP0 RPN1 RTN3 RABGAP1 PRUNE1 CLTC DLAT PRMT1 AFDN KIF5B SGIP1 ANK3 LMTK2 TACC2 PRDX2 APP MICU3 MTHFD1 CRYBG3	4.66e-07	1139	194	22	36417873
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ADCY9 USP31 SEMA6D DMD UTRN ANK3 RASA3 SEC31A APP RALGAPA2 CNNM3 SEC23IP XPR1	8.10e-07	421	194	13	36976175
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	CYLD USP34 ERCC4 DHX38 ZBTB41 ZRANB3 FMN1 CLTC TMX3 CPLANE1 MGA UTRN RHBDF1 ANK3 LMTK2 TACC2 SEC31A WDFY4 MTMR6 MTHFD1 CEP295	8.25e-07	1084	194	21	11544199
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	RELN PCDHA9 PCDHGB2 PCDHA7 NKX2-1 PCDHGB4	8.87e-07	58	194	6	30377227
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	EMC1 RPN1 RTN3 GFPT1 RINT1 NAA25 CLTC KIF5B TMX3 HSPA4 IQGAP3 NOC3L NDFIP2 APLP2 LRRC40 SEC31A APP CNNM3 SEC23IP	1.58e-06	942	194	19	31073040
Pubmed	Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration.	AKT1 DMD UTRN	1.69e-06	5	194	3	22734004
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	RABGAP1 KIF5B DMD UTRN CCDC14 IPO5 XPNPEP1 CEP295	2.28e-06	151	194	8	17043677
Pubmed	Genetically distinct subsets within ANCA-associated vasculitis.	F8 MAGEC2 COL11A2 PCDH11Y	2.70e-06	18	194	4	22808956
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	ATXN2L RPLP0 MCM3 NEK9 CLTC CPSF1 DLAT PRMT1 KIF5B MGA HSPA4 PRDX2 MTHFD1 GIGYF2	2.99e-06	551	194	14	34728620
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	RPLP0 RPN1 RTN3 MCM3 GFPT1 CLTC PRMT1 UTRN HSPA4 IQGAP3 IPO5 ANK3 NPEPPS XPNPEP1 PRDX2 MTHFD1 NT5C2	3.24e-06	807	194	17	30575818
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHA9 PCDHGB5 PCDHGB2 PCDH11Y PCDHA7 PCDHGB4	3.77e-06	74	194	6	10817752
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	RPN1 PPIL6 TIGD4 ZBTB41 GFPT1 ATAD2B CLTC VPS13A CPSF1 UTRN BANK1 NACC1 LRRC40 FRY MTHFD1 CEP295	4.29e-06	736	194	16	29676528
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	EMC1 RPN1 CDK12 DHX38 RSF1 MCM3 NEK9 GFPT1 MFAP1 CPSF1 PRMT1 KIF5B IPO5 DHX57 ERI1	4.48e-06	653	194	15	33742100
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CYLD USP34 RSF1 ABCA8 ADCY9 MFAP1 FAT1 DLAT TMX3 MGA NACC1 FAT3 APP RALGAPA2 CREBBP ZFHX4 CEP295 WDFY3 CRYBG3 TCTN2	4.92e-06	1116	194	20	31753913
Pubmed	Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members.	RELN APLP2 APP	5.88e-06	7	194	3	15385965
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHA9 PCDHGB5 PCDHGB2 PCDH11Y PCDHA7 PCDHGB4	5.95e-06	80	194	6	10716726
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CYLD USP34 ATXN2L DHX38 RTN3 MCM3 RABGAP1 CLTC CASP8AP2 USP28 TACC2 CREBBP CRYBG3 SPEN	6.28e-06	588	194	14	38580884
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	CDK12 F5 FAT1 CPLANE1 DNAH9 ANK3 SPTBN4 MICU3 ZFHX4 SPEN ATP4A	6.57e-06	361	194	11	26167880
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	EMC1 DHX38 ADCY9 USP31 RINT1 CLTC VPS13A CPSF1 DMD UTRN CCDC14 ANK3 NOC3L LMTK2 APLP2 APP CNNM3 MTMR6 CRYBG3	7.40e-06	1049	194	19	27880917
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	ATXN2L RPLP0 CDK12 CFL2 MCM3 NEK9 CLTC DLAT AFDN KIF5B HSPA4 IQGAP3 IPO5 ANK3 NACC1 NPEPPS SEC31A PRDX2 LAP3 MTHFD1	7.54e-06	1149	194	20	35446349
Pubmed	Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis.	ATXN2L RPLP0 MCM3 CLTC CPLANE1 HSPA4 IPO5 MTHFD1 GIGYF2	7.84e-06	236	194	9	36339263
Pubmed	MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.	RPLP0 MCM3 GFPT1 CLTC KIF5B IPO5 NPEPPS MTHFD1	9.06e-06	182	194	8	30711629
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	RPLP0 RPN1 CDK12 PRUNE1 CLTC DLAT PRMT1 TMX3 HSPA4 IPO5 USP28 NPEPPS SEC31A LAP3 MTHFD1 FLAD1 SEC23IP	9.75e-06	878	194	17	37223481
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	USP34 EMC1 GFPT1 PRUNE1 PRMT1 AFDN DMD TMX3 UTRN HSPA4 IPO5 NPEPPS POLE2 APLP2 CNNM3 MTMR6 FLAD1 XPR1	9.94e-06	974	194	18	28675297
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	SEMA6D FLT3 FAT3 PCDH11Y CDH9 EPHB1	1.25e-05	91	194	6	28558017
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	DDAH1 DMXL1 AKT1 CCDC14 CASP8AP2 NT5C2	1.33e-05	92	194	6	15840729
Pubmed	Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.	NUGGC ANK3 GDA	1.40e-05	9	194	3	20877300
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	RSF1 ADCY2 GFPT1 HOXB1 VPS13A NACC1 ADAM30 CREBBP DNAH7 SEC23IP CEP295 DSG4 WDFY3 SPEN	1.56e-05	638	194	14	31182584
Pubmed	Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation.	RPLP0 RPN1 MCM3 CLTC PRMT1 HSPA4 NPEPPS APLP2 MTHFD1	1.60e-05	258	194	9	21081666
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	DDAH1 RPLP0 CDK12 ABCA8 EXOC6B CPLANE1 HSPA4 IQGAP3 ITGA11 ERI1 RALGAPA2 NAPB TCTN2	1.90e-05	564	194	13	21565611
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	CYLD USP34 USP31 USP42 UTRN USP28 POLE2	1.99e-05	147	194	7	29576527
Pubmed	Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development.	RELN APLP2 APP	1.99e-05	10	194	3	16407979
Pubmed	Comprehensive analysis of the expression patterns of the adenylate cyclase gene family in the developing and adult mouse brain.	RELN ADCY2 ADCY9	1.99e-05	10	194	3	16615126
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	RPN1 MFAP1 CPSF1 AFDN NACC1 APLP2 LRRC40 GIGYF2	2.00e-05	203	194	8	22083510
Pubmed	Impaired Interneuron Development after Foxg1 Disruption.	RELN SEMA3A NKX2-1 EPHB1	2.00e-05	29	194	4	26620267
Pubmed	A human MAP kinase interactome.	CLTC KIF5B DMD CPLANE1 MGA CCDC14 CASP8AP2 ANK3 APLP2 SEC31A CREBBP GIGYF2	2.05e-05	486	194	12	20936779
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	USP34 RPLP0 DHX38 MCM3 RABGAP1 NEK9 GFPT1 PRMT1 KIF5B HSPA4 IPO5 RNASEH2B NPEPPS XPNPEP1 PRDX2 ERI1 LAP3 TRIM16 GDA MTHFD1 SEC23IP NT5C2	2.31e-05	1455	194	22	22863883
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 RABGAP1 NEK9 MGA UTRN CASP8AP2 NACC1 ZFHX4 SEC23IP GIGYF2 CRYBG3	2.56e-05	418	194	11	34709266
Pubmed	RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes.	RPLP0 RPN1 MCM3 CLTC PRMT1 HSPA4 NPEPPS PRDX2 MTHFD1 GIGYF2	2.59e-05	344	194	10	36282215
Pubmed	Absence of alpha-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin.	DMD UTRN ANK3	2.73e-05	11	194	3	10995443
Pubmed	Pih1d3 is required for cytoplasmic preassembly of axonemal dynein in mouse sperm.	DNAH9 DNAH7 DNAAF6	2.73e-05	11	194	3	24421334
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATXN2L RPLP0 RPN1 CDK12 CFL2 RSF1 MCM3 MFAP1 ATAD2B CLTC AFDN MBD4 MGA NOC3L MARF1 GIGYF2 SPEN	2.80e-05	954	194	17	36373674
Pubmed	BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.	RPN1 MCM3 GFPT1 CLTC MAGEC1 HSPA4 CRYBG3	2.91e-05	156	194	7	32850835
Pubmed	Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production.	DDAH1 PRMT1	3.10e-05	2	194	2	19682581
Pubmed	Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.	DMD UTRN	3.10e-05	2	194	2	10525423
Pubmed	Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.	F5 F8	3.10e-05	2	194	2	26599105
Pubmed	In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.	DMD UTRN	3.10e-05	2	194	2	28790199
Pubmed	Identification of the Alzheimer's disease amyloid precursor protein (APP) and its homologue APLP2 as essential modulators of glucose and insulin homeostasis and growth.	APLP2 APP	3.10e-05	2	194	2	18393365
Pubmed	The molecular basis of factor V and VIII procofactor activation.	F5 F8	3.10e-05	2	194	2	19765210
Pubmed	Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.	DMD UTRN	3.10e-05	2	194	2	26974331
Pubmed	Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines.	DMD UTRN	3.10e-05	2	194	2	7987307
Pubmed	Comparative analysis of the human dystrophin and utrophin gene structures.	DMD UTRN	3.10e-05	2	194	2	11861579
Pubmed	Distinct mechanical properties in homologous spectrin-like repeats of utrophin.	DMD UTRN	3.10e-05	2	194	2	30914715
Pubmed	Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.	DMD UTRN	3.10e-05	2	194	2	17889902
Pubmed	AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis.	APLP2 APP	3.10e-05	2	194	2	19403832
Pubmed	PRMT1-mediated arginine methylation controls ATXN2L localization.	ATXN2L PRMT1	3.10e-05	2	194	2	25748791
Pubmed	Regulation of estrogen rapid signaling through arginine methylation by PRMT1.	PRMT1 AKT1	3.10e-05	2	194	2	18657504
Pubmed	Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking.	F5 F8	3.10e-05	2	194	2	28057741
Pubmed	Embryonic stem cell-derived neurons as a cellular system to study gene function: lack of amyloid precursor proteins APP and APLP2 leads to defective synaptic transmission.	APLP2 APP	3.10e-05	2	194	2	18535156
Pubmed	Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice.	DMD UTRN	3.10e-05	2	194	2	37626761
Pubmed	The N- and C-Terminal Domains Differentially Contribute to the Structure and Function of Dystrophin and Utrophin Tandem Calponin-Homology Domains.	DMD UTRN	3.10e-05	2	194	2	26516677
Pubmed	Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging.	DMD UTRN	3.10e-05	2	194	2	22209498
Pubmed	The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels.	F5 F8	3.10e-05	2	194	2	15735794
Pubmed	Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.	DMD UTRN	3.10e-05	2	194	2	10694796
Pubmed	Differential distribution of Alzheimer's amyloid precursor protein family variants in human sperm.	APLP2 APP	3.10e-05	2	194	2	17405931
Pubmed	Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism.	F5 F8	3.10e-05	2	194	2	17287628
Pubmed	Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart.	DMD UTRN	3.10e-05	2	194	2	24337461
Pubmed	Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.	DMD UTRN	3.10e-05	2	194	2	11297940
Pubmed	Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.	DMD UTRN	3.10e-05	2	194	2	22388933
Pubmed	Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice.	APLP2 APP	3.10e-05	2	194	2	9461064
Pubmed	Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis.	DMD UTRN	3.10e-05	2	194	2	28785010
Pubmed	Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.	DMD UTRN	3.10e-05	2	194	2	16307000
Pubmed	Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2.	APLP2 APP	3.10e-05	2	194	2	15919150
Pubmed	Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice.	DMD UTRN	3.10e-05	2	194	2	21949353
Pubmed	Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.	DMD UTRN	3.10e-05	2	194	2	23097179
Pubmed	Kinesin-1 inhibits the aggregation of amyloid-β peptide as detected by fluorescence cross-correlation spectroscopy.	KIF5B APP	3.10e-05	2	194	2	26991731
Pubmed	The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain.	DMD UTRN	3.10e-05	2	194	2	15501597
Pubmed	Activated protein C has a regulatory role in factor VIII function.	F5 F8	3.10e-05	2	194	2	33512448
Pubmed	Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.	DMD UTRN	3.10e-05	2	194	2	18973234
Pubmed	Inter-individual variation in nucleotide excision repair pathway is modulated by non-synonymous polymorphisms in ERCC4 and MBD4 genes.	ERCC4 MBD4	3.10e-05	2	194	2	24004570
Pubmed	Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles.	DMD UTRN	3.10e-05	2	194	2	27881412
Pubmed	Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.	DMD UTRN	3.10e-05	2	194	2	29065908
Interaction	KCNA3 interactions	ATXN2L RPLP0 RPN1 MCM3 GFPT1 ADCY9 PRUNE1 VPS13A PRMT1 AFDN TRPM1 KIF5B HSPA4 IQGAP3 IPO5 ANK3 LRRC40 XPNPEP1 SEC31A MTHFD1 SEC23IP GIGYF2 CRYBG3 SPEN	3.30e-06	871	193	24	int:KCNA3
Interaction	ITGB3 interactions	ATXN2L DHX38 CLTC AKT1 KIF5B HSPA4 IPO5 NPEPPS APP MTHFD1	5.79e-06	170	193	10	int:ITGB3
Interaction	PCDHA7 interactions	PCDHA9 FLT3 PCDHA7 APP	7.57e-06	14	193	4	int:PCDHA7
Interaction	SIRT7 interactions	USP34 ATXN2L RPLP0 DHX38 RSF1 GFPT1 ATAD2B CLTC CPSF1 DLAT AFDN KIF5B UTRN HSPA4 IPO5 NPEPPS NOC3L DHX57 APP GIGYF2 SPEN	9.88e-06	744	193	21	int:SIRT7
Interaction	ABCC6 interactions	RPLP0 GFPT1 CLTC IPO5 SEC31A PRDX2	1.13e-05	53	193	6	int:ABCC6
Interaction	PCDHA9 interactions	PCDHA9 FLT3 PCDHGB5 PCDHGB2 PCDHA7	1.25e-05	32	193	5	int:PCDHA9
Interaction	LYN interactions	EMC1 ADCY9 USP31 MFAP1 VPS13A PRMT1 AFDN DMD UTRN BANK1 IPO5 RNASEH2B FLT3 ANK3 RASA3 LMTK2 NDFIP2 CREBBP CNNM3 XPR1	2.05e-05	720	193	20	int:LYN
Interaction	IQCH interactions	ETAA1 APP MTHFD1	2.94e-05	7	193	3	int:IQCH
Interaction	RYK interactions	F5 AFDN ANK3 PCDHGB5 NPEPPS FAT3 APLP2 CNNM3 DSG4 XPR1	3.93e-05	212	193	10	int:RYK
Interaction	PCDHGB3 interactions	PCDHGB5 PCDHGB2 PCDHGB4	4.67e-05	8	193	3	int:PCDHGB3
Interaction	PCDHA10 interactions	RELN PCDHA9 FLT3 PCDHA7	5.21e-05	22	193	4	int:PCDHA10
Interaction	EPHA2 interactions	ADCY9 USP31 SEMA6D CLTC AFDN AKT1 DMD UTRN HSPA4 ANK3 RASA3 SEC31A APP RALGAPA2 CNNM3 SEC23IP DNAJC5B EPHA5 XPR1	6.49e-05	719	193	19	int:EPHA2
Cytoband	5q31	PCDHA9 PCDHGB5 PCDHGB2 PCDHA7 PCDHGB4	1.35e-04	115	194	5	5q31
Cytoband	13q12	SACS FLT3 MTMR6	1.41e-04	24	194	3	13q12
GeneFamily	Ubiquitin specific peptidases	CYLD USP34 USP31 USP42 USP28	3.74e-05	56	122	5	366
GeneFamily	Clustered protocadherins	PCDHA9 PCDHGB5 PCDHGB2 PCDHA7 PCDHGB4	7.15e-05	64	122	5	20
GeneFamily	Aminopeptidases\|CD molecules	NPEPPS XPNPEP1 LAP3	1.90e-04	17	122	3	104
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DMD UTRN CREBBP	2.27e-04	18	122	3	91
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDFY4 WDFY3	1.58e-03	9	122	2	1230
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY2 ADCY9	1.96e-03	10	122	2	53
GeneFamily	Sterile alpha motif domain containing	SAMSN1 SEC23IP EPHA5 EPHB1	2.97e-03	88	122	4	760
Coexpression	GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP	ATXN2L PPIL6 FMN1 ETAA1 UTRN CCDC14 FAT3 RUBCNL ZBBX	1.23e-05	189	194	9	M7569
Coexpression	GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP	ATXN2L DHX38 BAAT ADCY9 ATAD2B PRMT1 DMD DNAH7 MARF1	1.78e-05	198	194	9	M5222
Coexpression	GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP	ADCY2 F8 FAM161A AFP VPS13A IPO5 NPEPPS GIGYF2 SPEN	1.86e-05	199	194	9	M8429
Coexpression	IKEDA_MIR30_TARGETS_UP	USP34 DDAH1 CFL2 SEMA3A SEMA6D DMD XPR1	2.58e-05	116	194	7	M2379
Coexpression	IKEDA_MIR30_TARGETS_UP	USP34 DDAH1 CFL2 SEMA3A SEMA6D DMD XPR1	2.73e-05	117	194	7	MM931
Coexpression	DURCHDEWALD_SKIN_CARCINOGENESIS_DN	SEMA6D FMN1 KIF5B TMX3 UTRN ANK3 APLP2 CREBBP CRYBG3 CCDC65	3.04e-05	265	194	10	M1684
Coexpression	DURCHDEWALD_SKIN_CARCINOGENESIS_DN	SEMA6D FMN1 KIF5B TMX3 UTRN ANK3 APLP2 CREBBP CRYBG3 CCDC65	3.79e-05	272	194	10	MM1027
Coexpression	BLALOCK_ALZHEIMERS_DISEASE_DN	PCDHA9 RTN3 ADCY2 F8 ADCY9 SACS SERGEF CLTC DLAT PRMT1 DMD MGA IPO5 CASP8AP2 ANK3 NPEPPS APLP2 TACC2 SEC31A PRDX2 APP MTHFD1 SEC23IP	5.42e-05	1248	194	23	M17728
Coexpression	GABRIELY_MIR21_TARGETS	USP34 DDAH1 RSF1 RABGAP1 ATAD2B VPS13A DMD MGA UTRN CCDC14	6.29e-05	289	194	10	M2196
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_500	OTOR SEMA3A TMEM132C SGIP1 ZFHX4 GIGYF2 EPHA5	2.35e-06	67	191	7	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_100	OTOR TMEM132C SGIP1 ZFHX4 EPHA5	3.15e-06	26	191	5	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500	SPTLC3 OTOR RABGAP1 GFPT1 SEMA3A TMEM132C USP31 CPLANE1 SGIP1 ANK3 FAT3 TSPAN2 ZFHX4 GIGYF2 EPHA5	4.60e-06	408	191	15	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500	SPTLC3 CDK12 OTOR RABGAP1 SEMA3A TMEM132C USP31 AFP CPLANE1 SGIP1 ANK3 FAT3 ZFHX4 GIGYF2	2.03e-05	407	191	14	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200	SPTLC3 OTOR SEMA3A TMEM132C USP31 FAT3 TSPAN2 ZFHX4 EPHA5	2.42e-05	170	191	9	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000	ERCC4 CDK12 RABGAP1 TMEM174 VPS13A KIF5B CPLANE1 UTRN ANK3	2.78e-05	173	191	9	gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200	SPTLC3 OTOR USP31 CPLANE1 SGIP1 FAT3 ZFHX4 NAPB EPHA5	3.48e-05	178	191	9	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#4_top-relative-expression-ranked_100	TMEM132C TRPM1 SGIP1 ZFHX4	4.09e-05	22	191	4	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_100_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_200	OTOR SGIP1 ZFHX4 EPHA5	4.91e-05	23	191	4	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_1000	SPTLC3 ERCC4 CDK12 CFL2 ZBTB41 RABGAP1 F5 HOXB1 TMEM174 FAM161A AFP VPS13A KIF5B CPLANE1 UTRN GPLD1 ANK3 KLF10 GIGYF2	8.91e-05	784	191	19	gudmap_developingLowerUrinaryTract_e15.5_urothelium_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_200	OTOR TMEM132C ZFHX4 EPHA5	1.10e-04	28	191	4	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_100	OTOR TMEM132C TRPM1 SGIP1 ZFHX4 EPHA5	1.19e-04	85	191	6	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_200	OTOR TMEM132C TRPM1 SGIP1 ZFHX4	1.24e-04	54	191	5	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	SPTLC3 ERCC4 CDK12 OTOR RABGAP1 SEMA3A TMEM132C USP31 FAM161A AFP CPLANE1 GPLD1 SGIP1 ANK3 FAT3 TSPAN2 ZFHX4 GIGYF2 EPHA5	1.28e-04	806	191	19	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500	SPTLC3 OTOR GFPT1 TMEM132C USP31 CPLANE1 SGIP1 FAT3 TSPAN2 ZFHX4 NAPB CNTN3 EPHA5	1.38e-04	427	191	13	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_200	SPTLC3 OTOR SEMA3A TMEM132C TRPM1 SGIP1 ZFHX4 EPHA5	1.50e-04	169	191	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	SPTLC3 CFL2 RSF1 OTOR RABGAP1 GFPT1 TMEM132C USP31 AFP CPLANE1 SGIP1 FAT3 APLP2 CREBBP TSPAN2 ZFHX4 NAPB CNTN3 EPHA5	1.54e-04	818	191	19	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500	SPTLC3 CDK12 OTOR TMEM132C USP31 AFP TRPM1 SGIP1 ZFHX4 GIGYF2 CNTN3 EPHA5	2.26e-04	390	191	12	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_200	TMEM132C TRPM1 SGIP1 ZFHX4	3.32e-04	37	191	4	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#5_top-relative-expression-ranked_200	OTOR TMEM132C ZFHX4 EPHA5	3.32e-04	37	191	4	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200_k5
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP34 RSF1 ZBTB41 CLTC CPLANE1 MGA UTRN FOXN2 GIGYF2 WDFY3 CRYBG3	9.45e-10	193	194	11	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	DDAH1 SMYD1 CFL2 EXOC6B DMD ANK3 TACC2 FRY XIRP2 XPR1	7.91e-09	182	194	10	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	Caecum-Dendritic_cell-cDC1\|Dendritic_cell / Region, Cell class and subclass	EMC1 DMXL1 SERGEF DLAT NAALADL1 APOL1 WDFY4 TSPAN2 CRYBG3	8.35e-08	176	194	9	07cde50e1c18fcc2c5028efe1a087db4ef4d4783
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	USP34 CDK12 RABGAP1 KIF5B CASP8AP2 CREBBP MARF1 GIGYF2 CEP295	1.34e-07	186	194	9	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB DNAAF6 CCDC65 TCTN2	2.00e-07	195	194	9	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PPIL6 ADCY2 DNAH9 DUOX2 TEX9 DNAH7 ZBBX ADGB CCDC65	2.48e-07	200	194	9	4992dbf0514d674017315dbd20d91dfec0c608e9
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN ADCY2 SEMA3A DMD DNAH9 FAT3 XIRP2 EPHA5	5.03e-07	159	194	8	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PKDREJ NEK9 FMN1 SGIP1 SPTBN4 NAPB PCDHGB4 DNAJC5B	6.07e-07	163	194	8	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	PPIL6 DNAH9 TEX9 DNAH7 TSPAN2 ADGB DNAAF6 CCDC65	7.29e-07	167	194	8	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN FAT1 DMD DNAH9 FAT3 ZFHX4 XIRP2 EPHA5	1.51e-06	184	194	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN FAT1 DMD DNAH9 FAT3 ZFHX4 XIRP2 EPHA5	1.51e-06	184	194	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN FAT1 DMD DNAH9 FAT3 ZFHX4 XIRP2 EPHA5	1.51e-06	184	194	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	ABCA8 TMEM132C AFDN FAT3 PCDH11Y RALGAPA2 CNTN3 CRYBG3	1.92e-06	190	194	8	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	SMYD1 EXOC6B DMD ANK3 TACC2 FRY XIRP2 XPR1	2.16e-06	193	194	8	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	SMYD1 EXOC6B DMD ANK3 TACC2 FRY XIRP2 XPR1	2.33e-06	195	194	8	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB CCDC65 TCTN2	2.33e-06	195	194	8	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.42e-06	196	194	8	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	Biopsy_Other_PF-Epithelial-Differentiating_Ciliated\|Biopsy_Other_PF / Sample group, Lineage and Cell type	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.81e-06	200	194	8	f7b4581d958afbd68f9045af619aaca0ab463439
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.81e-06	200	194	8	f1a49bc818054fb0734d3b84725ee6487b034567
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PPIL6 ADCY2 DNAH9 DUOX2 DNAH7 ZBBX ADGB CCDC65	2.81e-06	200	194	8	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PPIL6 ADCY2 DNAH9 DUOX2 DNAH7 ZBBX ADGB CCDC65	2.81e-06	200	194	8	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PPIL6 ADCY2 DNAH9 DUOX2 DNAH7 ZBBX ADGB CCDC65	2.81e-06	200	194	8	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	Parenchyma_COVID-19-Epithelial-TX-Ciliated\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.81e-06	200	194	8	d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.81e-06	200	194	8	cf59110547cc66b5f4a2999735336b0309ba9b0d
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL1 KIF5B TMX3 FLT3 MTERF1 DNAH7 FRY	5.63e-06	156	194	7	abea3c183d32062b009a79a2bdf861021989c7ef
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD244 SAMSN1 ADCY9 SERGEF WDFY4 GDA CRYBG3	6.38e-06	159	194	7	0c2437da5443fc3aff66f8ef311f02aa434a1fb0
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY2 SEMA3A DNAH9 FAT3 ZFHX4 CNTN3 EPHA5	6.65e-06	160	194	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY2 SEMA3A DNAH9 FAT3 ZFHX4 CNTN3 EPHA5	6.65e-06	160	194	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BAAT F5 DNAH9 FAT3 DUOX2 CNTN3 EPHA5	7.21e-06	162	194	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPIL6 CPLANE1 DNAH9 TEX9 DNAH7 ZBBX ADGB	9.51e-06	169	194	7	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	metastatic_Brain-Myeloid_cells-CD141+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	AARD BANK1 FLT3 NAALADL1 RUBCNL WDFY4 TSPAN2	1.15e-05	174	194	7	5ec8a48a390379d6c422120dce46437a77da67cc
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SEMA6D FMN1 UTRN ZBBX CNTN3 EPHA5 EPHB1	1.38e-05	179	194	7	c815eb9f760fe4ca7a5e49beb224659f0b864f22
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs\|Myeloid_cells / Location, Cell class and cell subclass	GFPT1 NAA25 FLT3 ANK3 TSPAN2 NAPB RORC	1.38e-05	179	194	7	5f7e6670a0e906a0a5bc75735408361d88e78fa2
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SEMA6D FMN1 AFP UTRN ZBBX CNTN3 EPHB1	1.43e-05	180	194	7	8923a42a6db9c6e9f3ce2ca9530e620dfea700ba
ToppCell	(01)_Cycling_Basal_(homeostasis)-(1)_24hpi\|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint	ARMCX4 ADCY9 NAA25 POLE2 TRIM16	1.46e-05	71	194	5	6aa56b0daaeb5e0ae30619f9c6945c8e42899b27
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN F5 SEMA3A FAT1 ITGA11 TSPAN2 FRY	1.48e-05	181	194	7	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN F5 SEMA3A FAT1 ITGA11 TSPAN2 FRY	1.48e-05	181	194	7	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN DDAH1 F8 FMN1 CCDC14 MTERF1 NOC3L	1.59e-05	183	194	7	919c9861073d12fd12aecd7469b1478b13838c43
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	EXOC6B DMD ANK3 TACC2 FRY XIRP2 XPR1	1.65e-05	184	194	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	RABGAP1 VPS13A MGA UTRN CCDC14 CASP8AP2 XPNPEP1	1.65e-05	184	194	7	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	COVID-19-Neuronal_cells-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	RELN F8 SEMA3A SGIP1 APP RALGAPA2 EPHB1	1.71e-05	185	194	7	4a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	EXOC6B DMD ANK3 TACC2 FRY XIRP2 XPR1	1.71e-05	185	194	7	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	COVID-19-Neuronal_cells\|COVID-19 / group, cell type (main and fine annotations)	RELN F8 SEMA3A SGIP1 APP RALGAPA2 EPHB1	1.71e-05	185	194	7	36ce23893915f5c380cca39b2c33a516edf31c3a
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	1.77e-05	186	194	7	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	1.77e-05	186	194	7	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	390C-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	1.83e-05	187	194	7	8896a00b30d11b90ca42726d4e122174a30b161b
ToppCell	18-Distal-Epithelial-Multiciliated_cell\|Distal / Age, Tissue, Lineage and Cell class	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	1.83e-05	187	194	7	8d7fa6b2950898e7f283401808378ba2a41b9651
ToppCell	390C-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	1.83e-05	187	194	7	88f785932e67c613db0dda84496de351359ed962
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPTLC3 PPIL6 FAM161A DNAH9 ZBBX ADGB CCDC65	1.96e-05	189	194	7	b55de812043b670cbde810d7d42f45909b6d66ef
ToppCell	Multiciliated\|World / shred by cell class for nasal brushing	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	1.96e-05	189	194	7	34b110aef839376228c5a403a6b5047a945f472b
ToppCell	Ciliated\|World / shred by cell class for parenchyma	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	1.96e-05	189	194	7	711181ca3b9102fb155168b646b0a9b09ff215b2
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPTLC3 PPIL6 FAM161A DNAH9 ZBBX ADGB CCDC65	1.96e-05	189	194	7	4e83e49d1265ffe507fdb72924c77c4d1c73f0bd
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.03e-05	190	194	7	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.03e-05	190	194	7	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-leukocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SAMSN1 GFPT1 FAM161A ATP6V1C2 COL11A2 PCDHA7 ZBBX	2.10e-05	191	194	7	116fba9badea093e11f370996247cca0e4c02e8f
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.17e-05	192	194	7	be592e661367affced9ebe80849b466e6adb3a34
ToppCell	PND03-Epithelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEMA3A CLTC ATP6V1C2 ANK3 APP NKX2-1 MTHFD1	2.17e-05	192	194	7	d8c23693f690d4d568585537bbfedda05d505b3d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPIL6 TEX9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.17e-05	192	194	7	1b6cac8156e608061e1405e36e18d185b6fa8f6f
ToppCell	PND03-Epithelial-Epithelial_Alveolar\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEMA3A CLTC ATP6V1C2 ANK3 APP NKX2-1 MTHFD1	2.24e-05	193	194	7	5dfa69a680a0859900141c40a446d217aaa747d3
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SEMA3A CLTC ATP6V1C2 ANK3 APP NKX2-1 MTHFD1	2.24e-05	193	194	7	ebea35704ac5d21e947ae094313cf2a5205e7014
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FAM161A CPLANE1 DNAH9 ANK3 DNAH7 ZBBX ADGB	2.24e-05	193	194	7	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB CCDC65	2.24e-05	193	194	7	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.24e-05	193	194	7	0b62a6ddd7c42efd9f39781971d1438501e1fa8d
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.32e-05	194	194	7	b4ce60c06568123008b1081d644733cb91c28f51
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB CCDC65	2.32e-05	194	194	7	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	ASK452-Epithelial-Ciliated\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	DNAH9 TEX9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.32e-05	194	194	7	5aeb44657ab6f61b1abf98af28d3397d8e44c1aa
ToppCell	Bronchial_Brush-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.32e-05	194	194	7	7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3
ToppCell	wk_15-18-Epithelial-Proximal_epithelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.32e-05	194	194	7	b0477583301dc6d9767b667bd2f8f94fbfaa6f81
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.32e-05	194	194	7	a46238514bca920c3e3713d23c18ba24a09e2a29
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPIL6 DUOX2 TEX9 DNAH7 ZBBX ADGB CCDC65	2.40e-05	195	194	7	d211a836cf711fdb91b10d512f09d462be937cc5
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.40e-05	195	194	7	93b1559382a12cfb158aa5fac7386e38b4f87989
ToppCell	NS-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.40e-05	195	194	7	34e37cff4849696ca4ba5dd8fd2cf98fed8bc912
ToppCell	BL-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.40e-05	195	194	7	07a6bcef6af93ed87df455dee624037cb75e011a
ToppCell	cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.40e-05	195	194	7	d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.40e-05	195	194	7	0e763f36786515698b593e5c93f6a56619c1242d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.40e-05	195	194	7	581b04220587e1d5198b1abd6965965ace7803e7
ToppCell	Control_saline-Epithelial_airway-airway_epithelial-Ciliated\|Control_saline / Treatment groups by lineage, cell group, cell type	PPIL6 ADCY2 DNAH9 DNAH7 ZBBX ADGB CCDC65	2.40e-05	195	194	7	60067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell	facs-Lung-nan-3m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN F8 SEMA3A UTRN DUOX2 APLP2 APP	2.40e-05	195	194	7	7f9b7f15006610ad591063d90e90367bd6083c7f
ToppCell	cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.40e-05	195	194	7	e7f069f557a59ee7b502ff82ad4c9f47fa619ba8
ToppCell	Severe_COVID-19-Epithelial-Ciliated\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.48e-05	196	194	7	1cdef976a754c90d18b6149d367bd64e6e99b0a9
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.48e-05	196	194	7	69f5081e06d84ec1d9695762df801a9d0df1984b
ToppCell	facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FMN1 AFDN DMD APLP2 TACC2 APP TSPAN2	2.48e-05	196	194	7	90edf61116ffcb4f8b6be3d0a05732d59b0a87d5
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.48e-05	196	194	7	686a5a0ddb00929842c1c98445c59edfcc9a8a04
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FMN1 AFDN DMD APLP2 TACC2 APP TSPAN2	2.48e-05	196	194	7	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.48e-05	196	194	7	67aefc480714e4b8c9ae53c036efdc07ec6f94af
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.48e-05	196	194	7	ca56311edc6788e032e7635fa69b1e07035202b5
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.56e-05	197	194	7	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB CCDC65	2.64e-05	198	194	7	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	medial-Epithelial-Ciliated\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB DNAAF6	2.73e-05	199	194	7	a2daa42b100c422dc8c04fb7d2ebf54293eef574
ToppCell	proximal-Epithelial-Ciliated\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.73e-05	199	194	7	9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76
ToppCell	medial-Epithelial-Ciliated-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB DNAAF6	2.73e-05	199	194	7	526002f16bbf61cf086278d45a401cc0b0b757a8
ToppCell	distal-Epithelial-Ciliated\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.73e-05	199	194	7	18ca031cfe702afb9bf94e03c0f3680c38e7599e
ToppCell	medial-2-Epithelial-Ciliated\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PPIL6 DNAH9 TEX9 DNAH7 ZBBX ADGB DNAAF6	2.73e-05	199	194	7	c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7
ToppCell	proximal-3-Epithelial-Ciliated\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.73e-05	199	194	7	1188afad6fd5f01f9aeba225f611f38b237dd2c9
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	OTOR TMEM132C FAT1 DMD CNTFR ANK3 ZFHX4	2.73e-05	199	194	7	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	proximal-Epithelial-Ciliated-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.73e-05	199	194	7	2e8ace105c4e2405baa06d953e52888b54e2d055
ToppCell	distal-2-Epithelial-Ciliated\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.73e-05	199	194	7	97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.82e-05	200	194	7	55c148238d5c80c1faa3428a917ae8075be2c145
ToppCell	Biopsy_IPF-Epithelial-Ciliated\|Biopsy_IPF / Sample group, Lineage and Cell type	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.82e-05	200	194	7	bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PPIL6 DNAH9 DNAH7 ZBBX ADGB DNAAF6 CCDC65	2.82e-05	200	194	7	8441e289377215a6877640946fe3f6de1f456502
Disease	superior crus of antihelix expression	BANK1 XPNPEP1	4.12e-05	2	190	2	EFO_0007673
Disease	handedness	ATXN2L RSF1 FOXN2 TEX9 PCDHGB4 CNTN3	6.59e-05	106	190	6	EFO_0009902
Disease	Chediak-Higashi syndrome (implicated_via_orthology)	WDFY4 WDFY3	2.45e-04	4	190	2	DOID:2935 (implicated_via_orthology)
Disease	hepatitis (biomarker_via_orthology)	F5 AFP	2.45e-04	4	190	2	DOID:2237 (biomarker_via_orthology)
Disease	Down syndrome (is_marker_for)	RELN NAPB MTHFD1	3.70e-04	22	190	3	DOID:14250 (is_marker_for)
Disease	choreatic disease (is_implicated_in)	VPS13A NKX2-1	4.07e-04	5	190	2	DOID:12859 (is_implicated_in)
Disease	Diffuse Large B-Cell Lymphoma	CLTC SEC31A CREBBP SPEN	4.40e-04	55	190	4	C0079744
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	SEMA3A BANK1 FOXN2 ANK3 NT5C2	5.05e-04	101	190	5	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	mental development measurement	PCDHGB5 PCDHGB2 PCDHGB4	5.44e-04	25	190	3	EFO_0008230
Disease	pappalysin-1 measurement	USP34 RPN1	6.08e-04	6	190	2	EFO_0802845
Disease	Iron deficiency anemia	F5 DUOX2	6.08e-04	6	190	2	HP_0001891
Disease	Alzheimer's disease 1 (implicated_via_orthology)	APLP2 APP	8.48e-04	7	190	2	DOID:0080348 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of ovary	ERCC4 CDK12 AKT1	8.49e-04	29	190	3	C0496920
Disease	Ovarian Carcinoma	ERCC4 CDK12 AKT1	9.39e-04	30	190	3	C0029925
Disease	proteoglycan 3 measurement	USP34 RPN1	1.13e-03	8	190	2	EFO_0802970
Disease	cognitive disorder (is_implicated_in)	DMD APP	1.44e-03	9	190	2	DOID:1561 (is_implicated_in)
Disease	Kartagener Syndrome	DNAH9 DNAAF6 CCDC65	1.48e-03	35	190	3	C0022521
Disease	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	DNAH9 DNAAF6 CCDC65	1.48e-03	35	190	3	C4551906
Disease	Polynesian Bronchiectasis	DNAH9 DNAAF6 CCDC65	1.48e-03	35	190	3	C4317124
Disease	Manic	RELN ADCY2 HSPA4 ANK3	1.64e-03	78	190	4	C0338831
Disease	bipolar I disorder	ADCY2 ANK3 XPNPEP1 ERI1 CNNM3	2.24e-03	141	190	5	EFO_0009963
Disease	cleft palate (is_implicated_in)	COL11A2 MTHFD1	2.61e-03	12	190	2	DOID:674 (is_implicated_in)
Disease	anxiety disorder, stress-related disorder	ADCY2 GIGYF2	2.61e-03	12	190	2	EFO_0006788, EFO_0010098
Disease	acute myeloid leukemia (implicated_via_orthology)	FLT3 CREBBP	2.61e-03	12	190	2	DOID:9119 (implicated_via_orthology)
Disease	hereditary spastic paraplegia (implicated_via_orthology)	RTN3 KIF5B SEC23IP	2.68e-03	43	190	3	DOID:2476 (implicated_via_orthology)
Disease	schizophrenia (is_marker_for)	RELN AKT1 ANK3	2.87e-03	44	190	3	DOID:5419 (is_marker_for)
Disease	late-onset Alzheimers disease	ABCA8 SEMA3A TRPM1 RHBDF1 ANK3 FAT3 APP	2.95e-03	292	190	7	EFO_1001870
Disease	esophagus squamous cell carcinoma (is_implicated_in)	FAT1 MBD4 SPEN	3.06e-03	45	190	3	DOID:3748 (is_implicated_in)
Disease	Congenital Hypothyroidism	DUOX2 NKX2-1	3.07e-03	13	190	2	C0010308
Disease	Endogenous depression	RELN APP CREBBP	3.25e-03	46	190	3	C0011573
Disease	Primary Ciliary Dyskinesia	DNAH9 DNAAF6 CCDC65	3.46e-03	47	190	3	C4551720
Disease	sunburn	ERCC4 TRPM1 SGIP1 ADAM30	3.49e-03	96	190	4	EFO_0003958
Disease	alpha fetoprotein measurement	USP34 NUGGC AFP NPEPPS	4.04e-03	100	190	4	EFO_0010583
Disease	sitting height ratio	HDHD2 ATAD2B EPHB1	4.36e-03	51	190	3	EFO_0007118
Disease	T-Cell Lymphoma	AKT1 MGA	4.66e-03	16	190	2	C0079772
Disease	Polyposis, Adenomatous Intestinal	F5 AKT1	4.66e-03	16	190	2	C2713442
Disease	Familial Intestinal Polyposis	F5 AKT1	4.66e-03	16	190	2	C2713443
Disease	Mood Disorders	RELN VPS13A AKT1 HSPA4 ANK3	4.74e-03	168	190	5	C0525045
Disease	chronotype measurement	USP34 RELN USP31 NAA25 SEMA6D ATAD2B SGIP1 ANK3 SLC44A2 ERI1 TEX14 NT5C2 EPHA5	4.87e-03	882	190	13	EFO_0008328
Disease	triacylglycerol 56:9 measurement	MAGEC1 MAGEC2	5.26e-03	17	190	2	EFO_0010436
Disease	Adenomatous Polyposis Coli	F5 AKT1	5.26e-03	17	190	2	C0032580
Disease	Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism	F5 SLC44A2	5.26e-03	17	190	2	EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140
Disease	urate measurement	USP34 DHX38 TMEM174 NAA25 FMN1 BANK1 NAALADL1 LMTK2 TEX14 APP KLF10 NT5C2 RORC	5.49e-03	895	190	13	EFO_0004531
Disease	pathological myopia	DNAH9 TACC2 ERI1 DNAJC5B	5.84e-03	111	190	4	EFO_0004207
Disease	caudal middle frontal gyrus volume measurement	FBP2 FRY	5.90e-03	18	190	2	EFO_0010290

Protein segments in the cluster

Peptide	Gene	Start	Entry
KDSEDYFEVNIPTDL	BANK1	156	Q8NDB2
KPQVTSETDTRYFDE	AKT1	426	P31749
KFFSLTETPEDYTII	CASTOR3	51	Q8NAP1
TDPADFAVAEALEKY	AFDN	271	P55196
SSASDFSDPVYKEIA	ERI1	56	Q8IV48
YELEITSDSQSPKDD	AARD	136	Q4LEZ3
RKPEVTDLEYFEEAA	BAAT	201	Q14032
PDSKEATVVYLAEDA	AGBL3	126	Q8NEM8
VIKPLVEYDDISSDS	CDK12	66	Q9NYV4
KTYPDTDSFNTVAEI	CPQ	261	Q9Y646
KIESLPKDTDQYFET	CRYBG3	551	Q68DQ2
KSPEYESLGFELTVE	NT5C2	61	P49902
TTAASTPDAVDKYLE	APP	366	P05067
PTSDKEYSAEEVAAA	ADGB	896	Q8N7X0
DDFSSPYQDEEVISK	CREBRF	121	Q8IUR6
FETEEEKVLPFYSSV	CCDC65	356	Q8IXS2
YIKIDTIAADESFTE	EPHA5	171	P54756
SPETVEEAQRKSTYE	GVINP1	656	Q7Z2Y8
ATEDRLTSAKELPYF	CREBBP	1526	Q92793
DLLVIADKYDPFTTT	POLE2	476	P56282
PSEISRKYQSEFEEI	DMD	1011	P11532
PEYDALTALVKETTD	CTBS	151	Q01459
FYVSPEDLEEQIKSD	DNAJC5B	151	Q9UF47
TQVPDIYEFLKDASD	CASP8AP2	1621	Q9UKL3
ETIEPDKTYENVLSS	CCDC14	716	Q49A88
VKAVAVDPTEEYFVT	DMXL1	2931	Q9Y485
ATAEDEAYAKPEAEA	ARMCX4	1056	Q5H9R4
SYTVPLEKDNSEEFR	ATXN2L	276	Q8WWM7
DIYTVKVEDLTFTSP	PRMT1	256	Q99873
FSVSDILSPLEESYK	NKX2-1	11	P43699
SSVDDYPVDTIAKRF	RAG1	546	P15918
TYEPDFNSAELLAKE	RUBCNL	331	Q9H714
DIIYSFSSDVSPDIK	PCDHA9	276	Q9Y5H5
YQEATKEVPTTDIDF	OTOR	111	Q9NRC9
STFVIDDPQETYKTL	RASA3	766	Q14644
DIRDPSEFEYLFSKD	FMN1	1011	Q68DA7
EKPYFTVSAESGELL	PCDHGB4	71	Q9UN71
EDTVVIASKPYAFDR	KIF5B	36	P33176
YKSEFPTEADLEDFT	APLP2	236	Q06481
YSKEKEDDVPQFTSA	LAP3	41	P28838
DIIYSFSSDVSPDIK	PCDHA7	276	Q9UN72
FTPVADEDSVVFSKL	RABGAP1	136	Q9Y3P9
YLAKTTEAEEVFVPV	PRUNE1	41	Q86TP1
EAPYLKVDTIAADES	EPHB1	131	P54762
FSTSKYEVVIPEDTA	FAT1	1456	Q14517
EDEEVYKRDFSAPTL	MFAP1	351	P55081
FSVSDILSPIEETYK	NKX2-4	11	Q9H2Z4
QLPEDKYLDSDASFT	MAP10	556	Q9P2G4
EPLFTYTLDEKVDEL	MAGEC1	901	O60732
PDSESSFTYTLDEKV	MAGEC2	131	Q9UBF1
SDPFVEAEKSNLAYD	HSPA4	76	P34932
LSAAFSESEKDTLPY	NEK9	831	Q8TD19
TDVYSNSDDDPILEK	MGA	411	Q8IWI9
SEYAEEFSKSEPAVV	MTMR6	596	Q9Y217
PFVTALEYATDTKAT	HDHD2	161	Q9H0R4
NIFSKPVDIEEVSDY	ATAD2B	981	Q9ULI0
ADSSLSEVAFSPKEY	C2CD6	496	Q53TS8
GDTVEDPYTSFVKLL	CFL2	61	Q9Y281
FPTLEKTSYSASIEE	DSG4	266	Q86SJ6
PKEYDLVLLFSSEEE	DUOX2	711	Q9NRD8
VSRDAKPLEVYSVDF	CPSF1	1246	Q10570
IFAIYRKTSEDEPSE	FBP2	136	O00757
KEADISAFADYRPTE	DLAT	296	P10515
SAFADYRPTEVTDLK	DLAT	301	P10515
ITTKDDLDFEIASSY	PCDHGB2	301	Q9Y5G2
EDELSPETSPYVKEF	COL11A2	1671	P13942
LTFPDYSDSTEVKFE	KDM4A	451	O75164
LSENYLTELPKDSFE	LRRC37B	586	Q96QE4
DVTVYLFDQETPTKE	LMTK2	1361	Q8IWU2
DLQEAKYETFSDDPS	F8	826	P00451
PSVKEFTETSAVFED	FMO6P	301	O60774
YDFILAVTTDEPKVA	MICU3	166	Q86XE3
YIIFDTEIESTSPKS	EXOC6B	251	Q9Y2D4
ETFLNEIKYIASDPD	ITGA11	311	Q9UKX5
VLDTADYVKPVTFSV	ITGA11	736	Q9UKX5
EKPYFTVSAESGELL	PCDHGB5	71	Q9Y5G0
PSEVDEIFDAISYSK	NPEPPSL1	426	A6NEC2
IASVADTAEEKFVPY	IPO5	516	O00410
VDIKPSALYDALTED	PPIL6	116	Q8IXY8
LSVETDYTFPLAEKV	RPLP0	251	P05388
LPSAEYSSVETDKKF	RALGAPA2	1241	Q2PPJ7
DTIKPNVDDSKEYFS	PRDX2	181	P32119
AEKFPDATDSEVYKV	IQGAP3	1156	Q86VI3
PSYIKDNFESARVTE	RELN	3266	P78509
TKEPETSNKYIDAFT	ETAA1	361	Q9NY74
VAFPSSSVYPTKDEE	MCM3	166	P25205
FDTTLLAEYPESSVK	METTL21C	241	Q5VZV1
TSLPTYDEAEKAKAA	NDFIP2	181	Q9NV92
APESLFEGIYTIKSD	FLT3	856	P36888
ASIPDFKEFYTESDV	ADCY2	891	Q08462
GEFDSYEVTIPEKLS	ADAM30	36	Q9UKF2
SFAPAYADLLSEDKE	HOXB1	151	P14653
TFVSFLKEVESPYEV	GIGYF2	1156	Q6Y7W6
KKETSEPEFSITENY	CPLANE1	2781	Q9H799
KALTFAETSEPVVYS	DHX57	396	Q6P158
ATAITFDEFTIVKPD	CNTFR	191	P26992
DTIKFEPELSDYIDI	DNAH7	411	Q8WXX0
FEKEVYDVSISEFSP	FAT3	376	Q8TDW7
TDIEYLAKVTFEESA	HYAL4	181	Q2M3T9
DFDELLSKPDYSSIE	ADCY9	1091	O60503
EVSYEFTSKTPDSLI	ANK3	3176	Q12955
DPESSIFIEDAIKYF	APOL1	61	O14791
FLEKYPSAEVARTAD	MBD4	481	O95243
KDKEETVFQVSYPSA	MARF1	721	Q9Y4F3
SSLSSVDEVYEFIPK	FOXN2	321	P32314
TFPEYKETTEESIKE	GDA	176	Q9Y2T3
DEKASAALYDFSVPS	KLF10	221	Q13118
STSNEAVYKIFDDSP	SLC44A2	386	Q8IWA5
LLIDDEYKVTAFPAT	EMC1	641	Q8N766
SESASLFEVNVPDYK	DNAH9	1276	Q9NYC9
KEASAVIAADPLYSD	FRY	2876	Q5TBA9
SAKAFYIPETETLEI	DNAAF6	186	Q9NQM4
YIDEVAEDPAKSLTE	CYLD	376	Q9NQC7
VSSSEEELPNLEKEY	FAM161A	171	Q3B820
SVVYAKDIAEIDDFS	GRK7	476	Q8WTQ7
SKELYVAADEASIAP	FLAD1	281	Q8NFF5
EASDYPAVSELSIEK	CEP295	2446	Q9C0D2
FKYKLVPEEETTASE	RSF1	706	Q96T23
NILEEYPSVSDIFKE	SACS	1466	Q9NZJ4
PVFTKVSYLIEVDED	CDH9	381	Q9ULB4
ETSPKEFLTIYEDVK	CD244	261	Q9BZW8
PSEVDEIFDAISYSK	NPEPPS	426	P55786
DIFPSVSLAYEKAES	ATP4A	826	P20648
VAYDEAKERASFITP	MTHFD1	256	P11586
YSSAELKVVASAPDF	CNTN3	396	Q9P232
KVEPLYELVTATDFA	C8B	466	P07358
AEILADTFKDYAVST	DDAH1	151	O94760
DTFKDYAVSTVPVAD	DDAH1	156	O94760
VVDETYVPPAFSDDK	AFP	516	P02771
YSDKQATLIPDEVFD	LRRC40	406	Q9H9A6
EIADVSSPTSDYVKI	PCDH11Y	831	Q9BZA8
SEVATESPLDFTKYL	NOC3L	781	Q8WTT2
PFKAYLDVDITLSSE	RTN3	911	O95197
RDFEYKSPEELESAV	UTRN	1151	P46939
SDIVSKEDFVLDSEY	ATP6V1C2	166	Q8NEY4
PADFKVLEASDLVYT	NUGGC	406	Q68CJ6
YLSPDAIEDTESQKA	SERGEF	416	Q9UGK8
DLSSISYEPDSSFKE	TEX14	1181	Q8IWB6
SVTPLDIYDTKDFSL	TMEM132C	721	Q8N3T6
SDDIPEDTTYKKVVF	F5	1606	P12259
YDFESETDTETIAKL	GFPT1	141	Q06210
FIYVDVISEEEAAPK	SAMSN1	216	Q9NSI8
VVKDPFYVIESLSDT	PKDREJ	826	Q9NTG1
EKLETFTPEDIVALY	FASTKD3	246	Q14CZ7
YPDEVFESPSEAALK	RHBDF1	276	Q96CC6
KISEGEELTVSYIDF	SMYD1	241	Q8NB12
YVRLDFSITKDPAAE	RPN1	456	P04843
LFAAKDIVPEEELSY	SETMAR	246	Q53H47
KSARPELYDETSFEL	SPTLC3	536	Q9NUV7
TDSRFIPYTEEFSEK	SEC23IP	351	Q9Y6Y8
LISESDNPEDDKVYF	SEMA3A	231	Q14563
ADKDEIPTISSYVDK	RD3L	161	P0DJH9
FDVASFLDKSEVPST	STRA8	251	Q7Z7C7
ESIKEFTANYPEEIV	ABCA8	111	O94911
FVKAETEKSDYDTPN	CHRM5	346	P08912
VKEAIDSYIKADDPS	CLTC	1121	Q00610
FKVSDDEYKVTISPQ	CNNM3	481	Q8NE01
FSASEEVVPEYVTLK	TMX3	181	Q96JJ7
IKTESEYEETFKPSS	XIRP2	216	A4UGR9
AYSSDTVENAEKIPE	XIRP2	456	A4UGR9
TQPLDSIKYFSDVEE	XIRP2	886	A4UGR9
APSVEVTDEDTVKRY	XPR1	36	Q9UBH6
PSLDVEVKDITDSYD	THEMIS	246	Q8N1K5
SDTFDPYLDITLEIK	USP42	251	Q9H9J4
EPQLESKSADFSDTY	ZFHX4	3331	Q86UP3
SDKASYAVSETIPKD	XPNPEP1	291	Q9NQW7
FTEDPRVFKVTYESE	VPS13A	2501	Q96RL7
FKEYTESSPSEDKVI	VPS13A	2581	Q96RL7
YDSEEVDLTNPKTFR	WDFY3	2736	Q8IZQ1
LYKELFSTETESPVG	RORC	501	P51449
TVREESLKFNPYDSS	SPEN	1301	Q96T58
DLPSYVSAFIEKEVG	RINT1	51	Q6NUQ1
LSDEPVEAKEDYTKF	RNASEH2B	251	Q5TBB1
QTFIKDDYLETISSP	SGIP1	386	Q9BQI5
LPVEYSSDDKIFQTE	ZBTB41	766	Q5SVQ8
ETLSEPNFYDTISKI	SMIM19	61	Q96E16
PTYDDVSKVAFLTVT	GPLD1	671	P80108
VTPETIVKSYEEAGF	TIGD4	366	Q8IY51
KDSYPVSSALFLEFE	WDFY4	296	Q6ZS81
TEEEVQKFVLSYPDV	MTERF1	306	Q99551
EAPDEKSIITYVVSF	SPTBN4	266	Q9H254
VDILFSKTPQEDYVE	DHX38	711	Q92620
NETKFSSPTEELDYR	TACC2	2506	O95359
SEAYTEAVKEFDSIS	NAPB	256	Q9H115
KYVIEFASTKPASES	USP28	446	Q96RU2
EETKITRYFPDETIN	TRPM1	1416	Q7Z4N2
YTPSTADIQVSDDDK	TMEM174	21	Q8WUU8
TEDITFPSVYVGLKD	TRIM16	291	O95361
ITADSETLPESEKYN	ERCC4	831	Q92889
YVDQSDSVDSSPVKE	USP31	991	Q70CQ4
PEARQAVFTAKYSED	USP34	1916	Q70CQ2
AIKELSSEDKSPEYF	TSPAN2	41	O60636
KAEADPLETSSYVSF	XKR5	476	Q6UX68
EALAAVLTYAKPDEF	SEC31A	651	O94979
AEAYKTSIDFPDETL	SEMA6D	376	Q8NFY4
SPKQDSSFEVYVDTD	TCTN2	256	Q96GX1
KYSDVQTADDVAIPE	TEX9	136	Q8N6V9
VAIPEDFSDFSLAKT	TEX9	146	Q8N6V9
EKLYSLTSEEFPDFS	ZBBX	716	A8MT70
PTKTAARDIIDYESD	ZRANB3	556	Q5FWF4
DSFFLPLKVSDYSET	NAALADL1	581	Q9UQQ1
VLKAEDDAYTTFISE	NACC1	481	Q96RE7
DDAYTTFISETGKIE	NACC1	486	Q96RE7
AFEPVVDLYSSLDAK	NAA25	521	Q14CX7